drugs
|
specialties
|
education
|
points
|
UnregisterUser
|
IsNClickFreeLimitExceeded: True
|
NClickFreeLimit: 0
|
Download App
Malaysia
search
Sign in
Home
Find Drugs
Pill Identifier
Find Drug Company
Country
China
Hong Kong
India
Indonesia
Malaysia
Myanmar
Philippines
Singapore
Thailand
Vietnam
Australia
Korea
New Zealand
search
UserName
Profession
Email
Account
Manage Account
Change Password
Sign Out
Home
Find Drugs
Pill Identifier
Find Drug Company
Others Services
Download App
Malaysia
China
Hong Kong
India
Indonesia
Malaysia
Myanmar
Philippines
Singapore
Thailand
Vietnam
Australia
Korea
New Zealand
More Services
drugs
|
specialties
|
education
|
points
|
UnregisterUser
|
IsNClickFreeLimitExceeded: True
|
NClickFreeLimit: 0
|
Manage Account
Sign in
Home
Find Drugs
Pill Identifier
Find Drug Company
MIMS home
Drugs
Info
Fenosup Lidose
Fenosup Lidose
fenofibrate
Manufacturer:
Hyphens
Distributor:
Zuellig Pharma
SELECT
Concise Prescribing Info
Full Prescribing Info
Contents
Description
Action
Indications/Uses
Dosage/Direction for Use
Overdosage
Contraindications
Special Precautions
Use In Pregnancy & Lactation
Adverse Reactions
Drug Interactions
Caution For Usage
Storage
MIMS Class
ATC Classification
Regulatory Classification
Presentation/Packing
Concise Prescribing Info
Full Prescribing Info
Contents
Description
Action
Indications/Uses
Dosage/Direction for Use
Overdosage
Contraindications
Special Precautions
Use In Pregnancy & Lactation
Adverse Reactions
Drug Interactions
Caution For Usage
Storage
MIMS Class
ATC Classification
Regulatory Classification
Presentation/Packing
Concise Prescribing Info
Contents
Fenofibrate
Indications/Uses
Hypercholesterolaemia & hypertriglyceridaemia alone or combined (types IIa, IIb, III, IV, V dyslipidaemias); secondary hyperlipoproteinaemias.
Click to view Fenosup Lidose detailed prescribing information
Dosage/Direction for Use
1 cap daily.
Click to view Fenosup Lidose detailed prescribing information
Overdosage
View
Fenosup Lidose overdosage
for action to be taken in the event of an overdose.
Administration
Should be taken with food: Take during meals. Swallow whole, do not chew/crush.
Contraindications
Renal & hepatic insufficiency eg, biliary cirrhosis. Gallbadder disease. Pregnancy & lactation. Childn.
Click to view Fenosup Lidose detailed prescribing information
Special Precautions
3 mthly monitoring of transaminase levels (discontinue if ASAT & ALAT levels is 3 times higher than normal). Patients treated concomitantly w/ HMG-CoA reductase inhibitors should be monitored for muscle toxicity.
Click to view Fenosup Lidose detailed prescribing information
Use In Pregnancy & Lactation
Click to view Fenosup Lidose detailed prescribing information
Adverse Reactions
Digestive, gastric or intestinal disorders (eg, abdominal pain, nausea, vomiting, diarrhoea & flatulence). Skin rashes, pruritus, urticaria, photosensitivity reactions (eg, cutaneous photosensitivity), erythema, vesiculation or nodulation.
Click to view Fenosup Lidose detailed prescribing information
Drug Interactions
Oral anticoagulants, cyclosporin, HMG-CoA reductase inhibitors.
Click to view Fenosup Lidose detailed prescribing information
Caution For Usage
For caution against possible variation of physical aspect of medicine...
Click to view Fenosup Lidose detailed prescribing information
Storage
View
Fenosup Lidose storage
conditions for details to ensure optimal shelf-life.
Description
View
Fenosup Lidose description
for details of the chemical structure and excipients (inactive components).
Action
View
Fenosup Lidose mechanism of action
for pharmacodynamics and pharmacokinetics details.
MIMS Class
Dyslipidaemic Agents
ATC Classification
C10AB05 - fenofibrate ; Belongs to the class of fibrates. Used in the treatment of hyperlipidemia.
Regulatory Classification
B
Presentation/Packing
Form
Fenosup Lidose cap 160 mg
Packing/Price
30's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Continue with Google
OR
Sign Up
Already a member?
Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Continue with Google
OR
Sign Up
Already a member?
Sign in